) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue ... 0.5 ... PUMA BIOTECHNOLOGY, INC ... C/O PUMA BIOTECHNOLOGY, INC., 10880 WILSHIRE BOULEVARD, SUITE 1700 3 ... C/O PUMA BIOTECHNOLOGY, INC ... Puma Biotechnology Inc.
Puma Biotechnology, Inc., a Delaware corporation (the "Company") held the 2026 Annual Meeting of Stockholders (the "2026 Annual Meeting") on June 11, 2026 at ... Puma Biotechnology Inc.
The proposed combination involves the acquisition by Ancat Holding GmbH (Ancat) (an indirect wholly owned subsidiary of ANTA) of 29.06% of the issued and outstanding share capital of PUMA SE (PUMA) by way of a secondary share purchase.